Table 4.
Parameter | Patient no. | CTL | Treg | CTL/Treg ratio | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline | After treatment | p Value | Baseline | After treatment | p Value | Baseline | After treatment | p Value | ||
Age (years) | 8 | |||||||||
≦60 | 11 | 27.6 ± 2.7 | 31.2 ± 2.9 | .10 | 2.6 ± 0.5 | 2.4 ± 0.6 | .52 | 15.9 ± 5.3 | 19.2 ± 4.2 | .33 |
>60 | 27.4 ± 3.2 | 29.5 ± 3.9 | .24 | 1.8 ± 0.3 | 1.6 ± 0.2 | .43 | 20.9 ± 5.2 | 23.3 ± 5.5 | .14 | |
Gender | ||||||||||
Male | 10 | 30.8 ± 2.9 | 34.7 ± 3.4 | .10 | 1.8 ± 0.3 | 1.5 ± 0.2 | .17 | 23.4 ± 5.5 | 28.2 ± 5.7 | <.02 |
Female | 9 | 23.9 ± 2.8 | 25.2 ± 3.1 | .22 | 2.6 ± 0.5 | 2.5 ± 0.6 | .78 | 13.7 ± 4.4 | 14.3 ± 2.8 | .82 |
Primary diagnosis | ||||||||||
Colorectal | 8 | 22.6 ± 2.5 | 24.5 ± 3.5 | .43 | 2.4 ± 0.3 | 2.2 ± 0.4 | .54 | 11.6 ± 3.4 | 15.7 ± 4.3 | .06 |
Soft tissue | 8 | 28.5 ± 2.4 | 32.1 ± 2.9 | .12 | 2.1 ± 0.5 | 2.0 ± 0.5 | .75 | 19.4 ± 4.5 | 20.3 ± 2.8 | .79 |
Lung | 2 | … | … | … | … | … | … | … | … | … |
Gynecologic | 1 | … | … | … | … | … | … | … | … | … |
Target tumor | ||||||||||
Primary | 3 | 27.5 ± 2.1 | 30.2 ± 2.5 | .21 | 2.1 ± 0.3 | 1.9 ± 0.3 | .11 | 18.8 ± 3.7 | 21.6 ± 3.6 | .54 |
Metastasis | 16 | 25.9 ± 2.3 | 28.5 ± 2.8 | .09 | 2.1 ± 0.2 | 1.8 ± 0.2 | .21 | 16.7 ± 3.7 | 20.7 ± 3.9 | <.02 |
Ablation site | ||||||||||
Lung | 7 | 27.9 ± 4.6 | 32.0 ± 5.3 | .07 | 1.8 ± 0.3 | 1.9 ± 0.5 | .71 | 23.2 ± 7.2 | 28.1 ± 7.9 | <.05 |
Soft tissue | 5 | 26.7 ± 2.7 | 31.1 ± 3.6 | .13 | 3.5 ± 0.5 | 2.6 ± 0.8 | .06 | 7.9 ± 0.8 | 14.4 ± 2.2 | <.03 |
Liver | 4 | 25.7 ± 2.2 | 29.4 ± 5.8 | .51 | 1.9 ± 0.2 | 1.7 ± 0.3 | .60 | 13.9 ± 2.0 | 17.8 ± 4.4 | .26 |
Bone | 3 | 31.3 ± 3.9 | 30.2 ± 4.0 | .20 | 1.0 ± 0.2 | 1.3 ± 0.2 | .11 | 32.0 ± 6.4 | 24.4 ± 2.5 | .19 |
Target tumor number | ||||||||||
Single | 16 | 27.1 ± 2.1 | 30.6 ± 2.9 | .05 | 2.2 ± 0.4 | 2.0 ± 0.4 | .39 | 18.3 ± 3.8 | 20.3 ± 3.5 | .35 |
2 or 3 | 3 | 28.4 ± 5.4 | 29.4 ± 5.3 | .59 | 2.1 ± 0.3 | 1.8 ± 0.6 | .59 | 19.9 ± 8.9 | 24.5 ± 8.9 | .12 |
Maximum diameter of target tumor (cm) | ||||||||||
≦2 | 13 | 24.4 ± 1.9 | 28.4 ± 2.8 | .35 | 2.1 ± 0.3 | 1.9 ± 0.3 | .82 | 15.5 ± 3.1 | 19.5 ± 3.4 | .06 |
>2 | 6 | 34.1 ± 4.6 | 34.2 ± 5.2 | .94 | 2.3 ± 0.7 | 2.0 ± 0.7 | .44 | 25.9 ± 9.4 | 26.1 ± 9.0 | .96 |
Ablation technique | ||||||||||
Heat-based ablation | 14 | 26.6 ± 2.7 | 29.0 ± 3.0 | .13 | 2.1 ± 0.3 | 1.9 ± 0.3 | .39 | 18.0 ± 4.4 | 21.6 ± 4.7 | <.02 |
Cryoablation | 5 | 29.9 ± 3.2 | 33.7 ± 4.6 | .24 | 2.3 ± 0.8 | 2.1 ± 0.9 | .66 | 21.0 ± 7.0 | 21.5 ± 4.3 | .92 |
Ablative zone area (cm2) | ||||||||||
≦10 | 11 | 25.5 ± 2.1 | 29.3 ± 3.3 | .08 | 2.4 ± 0.4 | 2.2 ± 0.4 | .32 | 14.5 ± 3.1 | 17.4 ± 3.3 | .09 |
>10 | 8 | 30.2 ± 4.1 | 31.5 ± 4.1 | .38 | 4.5 ± 0.5 | 3.9 ± 0.6 | .65 | 24.8 ± 7.3 | 27.5 ± 7.0 | .43 |
Data are presented as mean and standard error (SE).
CTL: cytotoxic T-lymphocyte; Treg: regulatory T-cell.